{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:25:21Z","timestamp":1767961521505,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.antiviral.2006.04.015","type":"journal-article","created":{"date-parts":[[2006,5,20]],"date-time":"2006-05-20T07:22:17Z","timestamp":1148109737000},"page":"201-205","source":"Crossref","is-referenced-by-count":21,"title":["Assembling a smallpox biodefense by interrogating 5-substituted pyrimidine nucleoside chemical space"],"prefix":"10.1016","volume":"71","author":[{"given":"Xuesen","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longhu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy A.","family":"Keith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Earl R.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F.","family":"Torrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.antiviral.2006.04.015_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.nrl.0000138998.11209.88","article-title":"Anticipating smallpox and monkeypox outbreaks: complications of the smallpox vaccine","volume":"10","author":"Abrahams","year":"2004","journal-title":"Neurologist"},{"issue":"1","key":"10.1016\/j.antiviral.2006.04.015_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1078-5337(03)00053-4","article-title":"Vaccines against biologic agents: uses and developments","volume":"10","author":"Ales","year":"2004","journal-title":"Respir. Care Clin. N. Am."},{"issue":"1","key":"10.1016\/j.antiviral.2006.04.015_bib3","first-page":"51","article-title":"Smallpox vaccination techniques: considerations and unresolved issues","volume":"144","author":"Balicer","year":"2005","journal-title":"Harefuah"},{"issue":"2 Pt 2","key":"10.1016\/j.antiviral.2006.04.015_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0755-4982(05)83899-0","article-title":"Risk of smallpox, vaccination, bioterrorism","volume":"34","author":"Bossi","year":"2005","journal-title":"Presse Med."},{"key":"10.1016\/j.antiviral.2006.04.015_bib5","series-title":"Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats","first-page":"17","article-title":"Viral bioterrorism and antiviral countermeasures","author":"Bray","year":"2005"},{"issue":"1","key":"10.1016\/j.antiviral.2006.04.015_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medmal.2003.03.003","article-title":"Vaccinal strategies against smallpox in France","volume":"34","author":"Bricaire","year":"2004","journal-title":"Med. Mal. Infect."},{"issue":"22","key":"10.1016\/j.antiviral.2006.04.015_bib7","doi-asserted-by":"crossref","first-page":"12147","DOI":"10.1128\/JVI.78.22.12147-12156.2004","article-title":"New class of orthopoxvirus antiviral drugs that block viral maturation","volume":"78","author":"Byrd","year":"2004","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.antiviral.2006.04.015_bib8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2003.11.053","article-title":"Smallpox vaccination and myopericarditis: a clinical review","volume":"43","author":"Cassimatis","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15\u201316","key":"10.1016\/j.antiviral.2006.04.015_bib9","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.vaccine.2004.01.023","article-title":"Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case\u2013control studies","volume":"22","author":"Chen","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.antiviral.2006.04.015_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.14.2.382-397.2001","article-title":"Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections","volume":"14","author":"De Clercq","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.antiviral.2006.04.015_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2004.05.004","article-title":"Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination","volume":"44","author":"Eckart","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.antiviral.2006.04.015_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1081-1206(10)61275-6","article-title":"Pre-event smallpox vaccination and postevent exposure and disease: a report of the Joint Task Force on Smallpox Vaccination for Allergists","volume":"94","author":"Ein","year":"2005","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.antiviral.2006.04.015_bib13","series-title":"Fileds Virology","first-page":"2885","article-title":"Poxviruses","author":"Esposito","year":"2001"},{"issue":"2","key":"10.1016\/j.antiviral.2006.04.015_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1172\/JCI24270","article-title":"Host-based antipoxvirus therapeutic strategies: turning the tables","volume":"115","author":"Fauci","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.antiviral.2006.04.015_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1345\/aph.1D272","article-title":"Smallpox: clinical features, prevention, and management","volume":"38","author":"Guharoy","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.antiviral.2006.04.015_bib16","first-page":"243","article-title":"Monitoring of human immunological responses to vaccinia virus","volume":"269","author":"Harrop","year":"2004","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.antiviral.2006.04.015_bib17","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/AAC.47.7.2193-2198.2003","article-title":"Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication","volume":"47","author":"Keith","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.antiviral.2006.04.015_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.artmed.2004.01.006","article-title":"Structural proteomics of the poxvirus family","volume":"31","author":"Randall","year":"2004","journal-title":"Artif. Intell. Med."},{"issue":"7","key":"10.1016\/j.antiviral.2006.04.015_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm1265","article-title":"Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases","volume":"11","author":"Reeves","year":"2005","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.antiviral.2006.04.015_bib20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cll.2004.05.002","article-title":"Emerging viral infections","volume":"24","author":"Su","year":"2004","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.antiviral.2006.04.015_bib21","series-title":"Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats","first-page":"3","article-title":"Introduction: pestilence, plague, bioterrorism","author":"Torrence","year":"2005"},{"issue":"3","key":"10.1016\/j.antiviral.2006.04.015_bib22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cll.2004.05.001","article-title":"Emerging infections in animals\u2014potential new zoonoses?","volume":"24","author":"Torres-Velez","year":"2004","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.antiviral.2006.04.015_bib23","series-title":"Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats","first-page":"31","article-title":"Overview of antiviral drug discovery and development","author":"Tseng","year":"2005"},{"issue":"20","key":"10.1016\/j.antiviral.2006.04.015_bib24","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2006.04.015_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI200523220","article-title":"Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction","volume":"115","author":"Yang","year":"2005","journal-title":"J. Clin. Invest."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206001240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206001240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T06:29:06Z","timestamp":1547620146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354206001240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":25,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0166354206001240"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2006.04.015","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}